| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.34 | 0.05 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.35 | 0.05 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.05 |